lobbying_activities: 3327532

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3327532	e0df904c-d6d1-4144-8b37-f405d3beb9e3	Q1	MEDSECUREAN.COM	401108536	INDIAN PHARMACEUTICAL ALLIANCE(FORMERLY INDIAN PHARMACEUTICAL ASSOCIATION)	2025	first_quarter	MMM	The Indian Pharmaceutical Alliance (IPA) actively supports targeted reforms in the U.S. healthcare system to ensure the sustainability of the generic drug industry. IPA advocates for meaningful reforms of Pharmacy Benefit Managers (PBMs) and Group Purchasing Organizations (GPOs) to secure transparent pricing and equitable market practices that directly benefit consumers. Moreover, IPA champions efforts to close loopholes in the Hatch-Waxman Act that impede timely generic drug market entry from remving patent thickets to generic first policies. These strategic initiatives are crucial for maintaining industry sustainability, reducing U.S. healthcare costs, and ensuring that effective, affordable treatment options remain accessible to all Americans. IPAs commitment to these reforms underscores its dedication to fostering a robust and enduring U.S.generic drug sector.	Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Federal Trade Commission (FTC),Health & Human Services, Dept of (HHS),White House Office	15000		0	0	2025-03-05T13:43:23-05:00